Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from ZBH

Earnings Preview: What To Expect From Zimmer Biomet’s Report

Here’s what analysts are expecting out of Zimmer Biomet’s upcoming Q2 earnings report.

Barchart

Is Zimmer Biomet Stock Underperforming the S&P 500?

Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.

Barchart

What Are Wall Street Analysts' Target Price for Zimmer Biomet Stock?

As Zimmer Biomet has lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know

Zimmer Biomet is poised to report its first-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

Barchart

How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?

Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.

Barchart

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.

MarketBeat

Zimmer Biomet Stock: Is Wall Street Bullish or Bearish?

Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Zimmer Biomet’s Q3 2025 Earnings: What to Expect

Zimmer Biomet is poised to report its fourth-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

Barchart

Zimmer Biomet Stock: Is ZBH Underperforming the Health Care Sector?

Despite Zimmer Biomet's underperformance relative to the broader healthcare sector over the past year, the stock is still viewed by analysts with moderate optimism.

Barchart

Zimmer Biomet Stock: Analyst Estimates & Ratings

Zimmer Biomet has significantly underperformed the broader market and other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

Is Zimmer Biomet Stock Underperforming the Dow?

Although Zimmer Biomet has lagged behind the Dow over the past year, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Zimmer Biomet Stock?

While Zimmer Biomet has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

Benzinga

What You Need To Know Ahead of Zimmer Biomet's Earnings Release

Zimmer Biomet is expected to announce its second-quarter results in the upcoming month, and analysts expect a low-single-digit drop in earnings.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Monday agreed to acquire Monogram Technologies Inc. (NASDAQ:MGRM) for an upfront payment of $4.04 per share, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million.

Barchart

Is Zimmer Biomet Stock Underperforming the Nasdaq?

Zimmer Biomet has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish?

Zimmer Biomet has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

What to Expect From Zimmer Biomet's Next Quarterly Earnings Report

Zimmer Biomet is gearing up to report its first-quarter results next month, with market expectations pointing to a single-digit decrease in earnings.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Zimmer Biomet Hits 34th 52-Week Low: Value Play or Value Trap?

Zimmer Biomet hit its 34th 52-week low on Tuesday. Its shares have decreased by over 20% in the past year. Trading at just 11.8x the 2025 EPS estimate, the maker of orthopedic medical devices looks cheap.

Barchart

Is Zimmer Biomet Stock Outperforming the S&P 500?

Zimmer Biomet has recently surged past the S&P 500 Index, with analysts maintaining a cautiously upbeat outlook on its growth potential.

Barchart

1 Stock to Buy ASAP to Cash in on the Pickleball Craze

As pickleball injuries rise, this medical device stock is perfectly positioned to cash in on the sport’s booming popularity.

StockNews.com

3 Healthtech Stocks Making Healthcare More Accessible

The healthcare market is fueling digital transformation by improving efficiency and fostering personalized care, making it an attractive investment opportunity. Hence, investors might consider investing in healthcare stocks, such as Teladoc Health (TDOC), Zimmer Biomet Holdings (ZBH), and Cardinal Health (CAH). Read more….

Barchart

Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink?

Despite trailing the broader market over the past year, Zimmer Biomet still holds a moderately favorable outlook among analysts.

Barchart

What to Expect From Zimmer Biomet’s Q4 2024 Earnings Report

Zimmer Biomet will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

StockNews.com

3 Healthcare Innovators Advancing Medical Technology

The healthcare industry is set for growth due to evolving healthcare demands and the rapid evolution of medical technologies. Hence, investors might consider investing in healthcare stocks, Becton, Dickinson and Co. (BDX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC). Read more….

1 2

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

404,588 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.